Novel treatment of meningitis caused by multidrug-resistant Mycobacterium tuberculosis with intrathecal levofloxacin and amikacin: Case report

Clinical Infectious Diseases

Volumn 32, Issue 4, 2001, Pages 643-646

  Berning, Shaun E ^a   Cherry, Teresa A ^b   Iseman, Michael D ^b  

^a NATIONAL JEWISH MEDICAL AND RESEARCH CENTER   (United States)

^b UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; CAPREOMYCIN; CYCLOSERINE; ETHAMBUTOL; ISONIAZID; LEVOFLOXACIN; PYRAZINAMIDE; RIFAMPICIN;

ACID FAST BACTERIUM; ADULT; ANTIBIOTIC THERAPY; ARTICLE; BACTERIUM CULTURE; CASE REPORT; CEREBROSPINAL FLUID ANALYSIS; HUMAN; MALE; MULTIDRUG RESISTANCE; MYCOBACTERIUM TUBERCULOSIS; PRIORITY JOURNAL; TREATMENT OUTCOME; TUBERCULOUS MENINGITIS;

ADULT; AMIKACIN; ANTI-BACTERIAL AGENTS; ANTI-INFECTIVE AGENTS; DRUG THERAPY, COMBINATION; HUMANS; INJECTIONS, SPINAL; MALE; MYCOBACTERIUM TUBERCULOSIS; OFLOXACIN; TUBERCULOSIS, MENINGEAL; TUBERCULOSIS, MULTIDRUG-RESISTANT;

EID: 0035864524     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/318698     Document Type: Article

References (10)

1. Antituberculosis drugs: Pharmacokinetics
2. Using therapeutic drug monitoring to dose the antimycobacterial drugs
3. Cerebrospinal fluid drug concentrations and the treatment of tuberculous meningitis
4. Penetration of pyrazinamide into the cerebrospinal fluid in tuberculous meningitis
5. Cerebrospinal fluid concentrations of ethionamide in children with tuberculous meningitis
6. The action of antituberculosis drugs in short-course chemotherapy
7. Pyrazinamide sterilizing activity in vitro against semidormant Mycobacterium tuberculosis bacterial populations
8. Predictors and outcome of multidrug-resistant tuberculosis
9. Antibiotic pharmacodynamics in cerebrospinal fluid
10. The clinical pharmacokinetics of levofloxacin